DSC Notice: To be completed by ISB
Date of Issue: To be completed by ISB
Table summarising the COVER return and the data items that have changed.
Data will be collected by: (i) PCT/LA responsible population* (until at least end 2014/15) and (ii) LA resident population*.
*See request parameters for population definitions
Antigen
DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib (primary)
MENC (primary)
Antigen
Abbreviation
D3 aP3
T3
Po3
Hib3
MenC
Number of children in cohort
12 months
Number vaccinated
%
Uptake
Number of children in cohort
Cohorts
24 months
Number vaccinated
%
Uptake
Number of children in cohort
5 years
Number vaccinated
%
Uptake
New or revised data for the
Quarterly and Annual COVER returns
No change
No change
No change
No change
No change.
Change from two to one dose
Report Primary course (one dose before
1 st birthday, or one dose thereafter).
No change PNEUMOCOCCAL
(primary)
ROTAVIRUS
Pnc n/a n/a n/a n/a n/a n/a
BCG (selective)
MMR1
Hib/MenC booster
Pnuemococccal booster
DIPHTHERIA booster
PERTUSSIS booster
TETANUS booster
Rota
BCG
MMR1
HibMenC
Pncb
D4 aP4
T4 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
NEW antigen
Report completed course
(2 doses before 24 weeks)
NEW antigen
Report one dose before 1 st birthday
No change
Report booster on or after 1 st
birthday or thereafter
No change
No change
No change
No change
POLIO booster
MMR2
Po4 n/a n/a n/a n/a n/a n/a No change
MMR2 n/a n/a n/a n/a n/a n/a No change
Hepatitis B vaccination data - Note that the existing Hepatitis B data items still form part of this collection and have not changed.
Templates for the whole revised COVER return are given below.

NHS Information Standards Board - DRAFT
The following groups of children are to be included as Primary Care Trust (PCT) or Local Authority (LA) responsible population for COVER data. Children for whom the PCT/LA is responsible are:
-
- all children registered with a GP whose practice forms part of the PCT/LA, regardless of where the child is resident, plus any children not registered with a GP, who are resident within the PCT's/LA’s statutory geographical boundary
Note that children resident within the PCT/LA geographical area, but registered with a GP belonging to another
PCT/LA, are the responsibility of that PCT/LA.
Request 1: 12 MONTH COHORT
1 Total number of children for whom the PCT/LA is responsible on yy/yy/yyyy reaching their 1 st birthday during the above evaluation quarter.
2 Total number and percentage vaccinated (to one decimal place) included in line 1 completing a primary course (3 doses of D,T,aP,Polio,Hib, 1 dose of MenC, 2 doses of pneumococcal, 2 dose
rotavirus vaccine, 1 dose BCG) at any time up to their 1 st birthday for each of the following: or (a) DTaP/IPV/Hib3 (a)
(b)
DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib
MenC
(D3)
(aP3)
(T3)
(Po3)
(Hib3)
(MenC)
(c)
(d)
(e)
PNEUMOCOCCAL
ROTAVIRUS
BCG
(Pnc2)
(Rota2)
(BCG)
NOTES for Request 1 :
(a) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV, and Hib vaccine before 1 st birthday will equate to a completed course.
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(d) Rotavirus vaccine - primary course is 2 doses given before 25 weeks.
(e) BCG vaccine - will provide data to calculate BCG coverage only for areas that are offering a universal neonatal
BCG programme (i.e. TB incidence >40/100,000) population.
DSCN Number – To be completed by ISB
Page 2 of 15

NHS Information Standards Board - DRAFT
Request 2: 24 MONTH COHORT
3 Total number of children for whom the PCT/LA is responsible on yy/yy/yyyy reaching their 2 nd birthday during the above evaluation quarter.
4 Total number and percentage vaccinated (to one decimal place) included in line 3 completing a
primary or booster course at any time up to their 2 nd birthday:
(f)
(g)
(h)
(i)
DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib
MMR
Hib/MenC booster
PNEUMO booster
(D3)
(P3)
(T3)
(Po3)
(Hib3)
(MMR1)
(Pncb)
(Hib/MenC)**** or (f) DTaP/IPV/Hib3***
NOTES for Request 2:
(f) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV vaccine before 2 nd birthday will equate to a completed course (Hib is evaluated as part of
Hib/MenC at 24 months, see (h)).
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(h) Although most children receive a Hib/MenC booster as one dose of combined Hib/MenC vaccine on or after 1 st birthday, children completing their primary course after 1 st birthday can be reported as having one dose of
DTaP/IPV/Hib (or any other Hib-containing vaccine) and one dose of MenC, both given on or after 1 st birthday and before 2 nd birthday
Request 3: 5 YEAR COHORT
5 Total number of children for whom the PCT/LA is responsible on yy/yy/yyyy reaching their 5 th birthday during the above evaluation quarter.
6 Total number and percentage vaccinated (to one decimal place) included in line 5 completing a
primary or booster course at any time up to their 5 th birthday:
(j) DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib
(D3)
(P3)
(T3)
(Po3)
(Hib3) or (j) DTaP/IPV/Hib3
7
(k)
(l)
MMR (1 dose)
TETANUS booster
POLIO booster
(m) Hib/MenC booster
(MMR1)
DIPHTHERIA booster (D4)
PERTUSSIS booster (aP4)
(T4)
(Po4)
(HibMenC) or (l) DTaP/IPV
(n) MMR (2 doses) (MMR2)
NOTES for Request 3:
(j) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV vaccine before 5 th birthday will equate to a completed course (Hib is evaluated as part of
Hib/MenC at 5 years, see (l)).
DSCN Number – To be completed by ISB
Page 3 of 15

NHS Information Standards Board - DRAFT
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(l) Although most children receive a Hib/MenC booster as one dose of combined Hib/MenC vaccine on or after 1 st birthday, children completing their primary course after 1 st birthday can be reported as having one dose of
DTaP/IPV/Hib (or any other Hib-containing vaccine) and one dose of MenC, both given on or after 1 st birthday and before 3 rd birthday
8
Request 4: Neonatal Hepatitis B 12 MONTH COHORT
Total number of children for whom the PCT/LA is responsible on yy/yy/yyyy with maternal
HB status positive (HBsAg+ve) and reaching their 1 st birthday during the above evaluation quarter
9 Total number included in line 7 and receiving a 3 rd dose of Hep B vaccine before their 1 st birthday (o)
Request 5: Neonatal Hepatitis B 24 MONTH COHORT
10 Total number of children for whom the PCT/LA is responsible on yy/yy/yyyy with maternal
HB status positive (HBsAg+ve) and reaching their 2 nd birthday during the above evaluation quarter
11 Total number included in line 7 and receiving a 4 th dose of Hep B vaccine before their 2 nd birthday (p)
NOTES for Requests 4 and 5 :
1.
Although some CHISs do not have the capacity to produce statistics or even hold information on hepatitis B vaccines, this information is requested in the same format as the current COVER outputs. This is designed to ensure that collection of hepatitis B data is integrated into the routine collection and coverage data can be compared. Where not available from the CHIS it is hoped that these data will be generated from manual systems or from standalone databases managed by or on behalf of the DIC.
2.
The format is based on the 0, 1, 2, 12 month schedules recommended in the HSC 1998.
3.
The HSC recommended universal screening of pregnant women from April 2000. Data on antenatal prevalence will be collected via Regions and can be used to validate the completeness of identification of children at risk in future cohorts.
4.
PHE have aimed only to collate information on completion of vaccination, although realises that first dose coverage and timeliness may be more important in the prevention of infection.
Please email a copy of the Child Health computer output page or completed request parameter template (see below) which includes the number of children for whom the PCT/LA is responsible in the specified cohorts, the number and percentage (accurate to one decimal place) completing the requested courses and return by yy/yy/yyyy plus two months to:
COVER@phe.gov.uk
e-mail or by post COVER Administrator
Immunisation, Hepatitis and Blood Safety Department,
PHE Centre for Infectious Disease Surveillance and Control
61 Colindale Avenue, London NW9 5EQ
Tel: 020 8327 6688 Fax: 020 8327 7404 / 020 8200 7868
DSCN Number – To be completed by ISB
Page 4 of 15

NHS Information Standards Board - DRAFT
Children to be included as upper tier Local Authority (LA) resident population for COVER data are all children who are resident within the LA's statutory geographical boundary.
Request 1: 12 MONTH COHORT
1 Total number of children resident in the LA on yy/yy/yyyy reaching their 1 st birthday during the above evaluation quarter.
2 Total number and percentage vaccinated (to one decimal place) included in line 1 completing a primary course (3 doses of D,T,aP,Polio,Hib, 1 dose of MenC, 2 doses of pneumococcal, 2 dose
rotavirus vaccine, 1 dose BCG) at any time up to their 1 st birthday for each of the following:
(a) DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
(D3)
(aP3)
(T3)
(Po3) or (a) DTaP/IPV/Hib3
(b)
Hib
MenC
(Hib3)
(MenC)
(c)
(d)
(e)
PNEUMOCOCCAL
ROTAVIRUS
BCG
(Pnc2)
(Rota2)
(BCG)
NOTES for Request 1 :
(b) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV, and Hib vaccine before 1 st birthday will equate to a completed course.
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(d) Rotavirus vaccine - primary course is 2 doses given before 25 weeks.
(e) BCG vaccine - will provide data to calculate BCG coverage only for areas that are offering a universal neonatal
BCG programme (i.e. TB incidence >40/100,000) population.
DSCN Number – To be completed by ISB
Page 5 of 15

NHS Information Standards Board - DRAFT
Request 2: 24 MONTH COHORT
3 Total number of children resident in the LA on yy/yy/yyyy reaching their 2 nd birthday during the above evaluation quarter.
4 Total number and percentage vaccinated (to one decimal place) included in line 3 completing a
primary or booster course at any time up to their 2 nd birthday:
(f)
(g)
(h)
(i)
DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib
MMR
Hib/MenC booster
PNEUMO booster
(D3)
(P3)
(T3)
(Po3)
(Hib3)
(MMR1)
(Pncb)
(Hib/MenC)**** or (f) DTaP/IPV/Hib3***
NOTES for Request 2:
(f) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV vaccine before 2 nd birthday will equate to a completed course (Hib is evaluated as part of
Hib/MenC at 24 months, see (h)).
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(h) Although most children receive a Hib/MenC booster as one dose of combined Hib/MenC vaccine on or after 1 st birthday, children completing their primary course after 1 st birthday can be reported as having one dose of
DTaP/IPV/Hib (or any other Hib-containing vaccine) and one dose of MenC, both given on or after 1 st birthday and before 2 nd birthday
Request 3: 5 YEAR COHORT
5 Total number of children resident in the LA on yy/yy/yyyy reaching their 5 th birthday during the above evaluation quarter.
6 Total number and percentage vaccinated (to one decimal place) included in line 5 completing a
primary or booster course at any time up to their 5 th birthday:
(j) DIPHTHERIA
PERTUSSIS
TETANUS
POLIO
Hib
(D3)
(P3)
(T3)
(Po3)
(Hib3) or (j) DTaP/IPV/Hib3
7
(k)
(l)
MMR (1 dose) (MMR1
DIPHTHERIA booster (D4)
PERTUSSIS booster (aP4)
TETANUS booster
POLIO booster
(m) Hib/MenC booster
(T4)
(Po4)
(HibMenC) or (l) DTaP/IPV
(n) MMR (2 doses) (MMR2)
NOTES for Request 3:
(j) DTaP/IPV/Hib is currently the only vaccine available in the UK for primary immunisations and some CHISs may output this variable rather than individual D3, aP3, T3, Pol3, Hib variables. In this case, for children living in but immunised outside the UK who may have been given different vaccine combinations, 3 doses of each of DTP or
DTaP, IPV or OPV vaccine before 5 th birthday will equate to a completed course (Hib is evaluated as part of
Hib/MenC at 5 years, see (l)).
DSCN Number – To be completed by ISB
Page 6 of 15

NHS Information Standards Board - DRAFT
This only affects a small number of children but is more significant in areas with a higher proportion of movers in from outside the UK.
(l) Although most children receive a Hib/MenC booster as one dose of combined Hib/MenC vaccine on or after 1 st birthday, children completing their primary course after 1 st birthday can be reported as having one dose of
DTaP/IPV/Hib (or any other Hib-containing vaccine) and one dose of MenC, both given on or after 1 st birthday and before 3 rd birthday
8
Request 4: Neonatal Hepatitis B 12 MONTH COHORT
Total number of children resident in the LA on yy/yy/yyyy with maternal HB status positive
(HBsAg+ve) and reaching their 1 st birthday during the above evaluation quarter
9 Total number included in line 7 and receiving a 3 rd dose of Hep B vaccine before their 1 st birthday (o)
Request 5: Neonatal Hepatitis B 24 MONTH COHORT
10 Total number of children resident in the LA on yy/yy/yyyy with maternal HB status positive
(HBsAg+ve) and reaching their 2 nd birthday during the above evaluation quarter
11 Total number included in line 7 and receiving a 4 th dose of Hep B vaccine before their 2 nd birthday (p)
NOTES for Requests 4 and 5 :
5.
Although some CHISs do not have the capacity to produce statistics or even hold information on hepatitis B vaccines, this information is requested in the same format as the current COVER outputs. This is designed to ensure that collection of hepatitis B data is integrated into the routine collection and coverage data can be compared. Where not available from the CHIS it is hoped that these data will be generated from manual systems or from standalone databases managed by or on behalf of the DIC.
6.
The format is based on the 0,1,2,12 month schedules recommended in the HSC 1998.
7.
The HSC recommended universal screening of pregnant women from April 2000. Data on antenatal prevalence will be collected via Regions and can be used to validate the completeness of identification of children at risk in future cohorts.
8.
PHE have aimed only to collate information on completion of vaccination, although realises that first dose coverage and timeliness may be more important in the prevention of infection.
Please email a copy of the Child Health computer output page or completed request parameter template (see below) which includes the number of children for whom the LA is responsible in the specified cohorts, the number and percentage (accurate to one decimal place) completing the requested courses and return by yy/yy/yyyy plus two months to: e-mail COVER@phe.gov.uk
or by post COVER Administrator
Immunisation, Hepatitis and Blood Safety Department,
PHE Centre for Infectious Disease Surveillance and Control
61 Colindale Avenue, London NW9 5EQ
Tel: 020 8327 6688 Fax: 020 8327 7404 / 020 8200 7868
DSCN Number – To be completed by ISB
Page 7 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 8 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 9 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 10 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 11 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 12 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 13 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 14 of 15

NHS Information Standards Board - DRAFT
DSCN Number – To be completed by ISB
Page 15 of 15